Abstract
Zidovudine (azidothymidine, AZT) is used in pregnancy to reduce mother to infant transmission of HIV. Understanding the disposition of AZT in the fetus is necessary to optimize therapeutic regimens directed toward the fetus. Recent studies in primates found similar steady-state levels of the glucuronide metabolite of AZT (AZT-glu) in the fetus to those in the mother, raising the question of whether metabolite was of fetal or maternal origin. The objective of this study was to determine whether glucuronidation occurred in the fetal compartment and to quantify the placental and fetal clearances of AZT using the two-compartment model at steady state. Steady-state concentrations were obtained after paired maternal and fetal infusions of AZT in chronically catheterized pregnant baboons. During maternal infusion, the mean (±SE) fetal to maternal ratio of AZT was <1 (0.84 ± 0.06, p < 0.02), suggesting clearance of AZT in the fetus. Mean total maternal clearance of AZT was 725 ± 49 mL/min and placental clearance was 36 ± 4 mL/min, or ∼5% of maternal clearance. Fetal clearance of AZT was estimated at ∼15% of placental clearance. This suggests fetal nonplacental clearance is minimal compared with that in the mother, but does not preclude the fetus from actively contributing to the metabolite in the fetal circulation. During infusion of AZT to the fetus, the concentration of AZT-glu in the fetus was 7.0 ± 0.8 times that in the mother. This is compelling evidence that glucuronide can be formed in the fetal compartment. Thus, fetal metabolism has an impact on the concentration of both AZT and AZT-glu in the fetal circulation.
Similar content being viewed by others
Log in or create a free account to read this content
Gain free access to this article, as well as selected content from this journal and more on nature.com
or
Abbreviations
- AZT, :
-
azidothymidine; zidovudine
- AZT-glu, :
-
glucuronide metabolite of zidovudine
- CV, :
-
coefficient of variation
References
Connor EM, Mofenson LM 1995 Zidovudine for the reduction of perinatal human immunodeficiency virus transmission: pediatric AIDS Clinical Trials Group Protocol 076[em]results and treatment recommendations. Pediatr Infect Dis J 14: 536–541.
Connor EM, Sperling RS, Gelber R, Kiselev P, Scott G, O'Sullivan MJ, VanDyke R, Bey M, Shearer W, Jacobson RL 1994 Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. Pediatric AIDS Clinical Trials Group Protocol 076 Study Group. N Engl J Med 331: 1173–1180.
Fast P, Newell M-L, Mofenson L, Ammann A, Rossi P, Siena Consensus Workshop II 1995 Strategies for prevention of perinatal transmission of HIV infection. J Acquir Immune Defic Syndr 8: 161–175.
Dickover RE, Garratty EM, Herman SA, Sim MS, Plaeger S, Boyer PJ, Keller M, Deveikis A, Stiehm ER, Bryson YJ 1996 Identification of levels of maternal HIV-1 RNA associated with risk of perinatal transmission. Effect of maternal zidovudine treatment on viral load. JAMA 275: 599–605.
Sperling RS, Shapiro DE, Coombs RW, Todd JA, Herman SA, McSherry G, O'Sullivan MJ, Van Dyke RB, Jimenez E, Rouzioux C, Flynn PM, Sullivan JL 1996 Maternal viral load, zidovudine treatment, and the risk of transmission of human immunodeficiency virus type 1 from mother to infant. N Engl J Med 335: 1621–1629.
Garland M, Stark RI, Szeto HH, Myers MM 1994 Exposure to zidovudine in the fetal baboon. Pediatr Res 35: 84A
Lopez-Anaya A, Unadkat JD, Schumann LA, Smith AL 1990 Pharmacokinetics of zidovudine (azidothymidine). I. Transplacental transfer. J Acquir Immune Defic Syndr 3: 959–964.
Szeto HH, Umans JG, Rubinow SI 1982 The contribution of transplacental clearances and fetal clearance to drug disposition in the ovine maternal-fetal unit. Drug Metab Dispos 10: 382–386.
Coughtrie MW, Burchell B, Leakey JE, Hume R 1988 The inadequacy of perinatal glucuronidation: immunoblot analysis of the developmental expression of individual UDP-glucuronosyltransferase isoenzymes in rat and human liver microsomes. Mol Pharmacol 34: 729–735.
Dvorchik BH, Woodward G, Sitar DS, Tweed WA 1986 Hydroxylation and glucuronidation of various xenobiotics by hepatic microsomes from the fetal lamb, pregnant ewe and human fetus. Dev Pharmacol Ther 9: 282–289.
Olsen GD, Norris SR, Sommer KM, Grosso SM 1989 Placental permeability for morphine-3-β-D-glucuronide in the guinea pig. Placenta 10: 83–93.
Olsen GD, Sommer KM, Wheeler PL, Boyea SR, Michelson SP, Cheek DB 1988 Accumulation and clearance of morphine-3-β-D-glucuronide in fetal lambs. J Pharmacol Exp Ther 247: 576–584.
Stark RI, Daniel SS, James LS, MacCarter G, Morishima HO, Niemann WH, Rey H, Tropper PJ, Yeh MN 1989 Chronic instrumentation and longterm investigation in the fetal and maternal baboon: tether system, conditioning procedures and surgical techniques. Lab Anim Sci 39: 25–32.
Collins JM, Klecker RW Jr, Kelley JA, Roth JS, McCully CL, Balis FM, Poplack DG 1988 Pyrimidine dideoxyribonucleosides: selectivity of penetration into cerebrospinal fluid. J Pharmacol Exp Ther 245: 466–70.
Liebes L, Mendoza S, Wilson D, Dancis J 1990 Transfer of zidovudine (AZT) by human placenta. J Infect Dis 161: 203–207.
Schenker S, Johnson RF, King TS, Schenken RS, Henderson GI 1990 Azidothymidine (zidovudine) transport by the human placenta. Am J Med Sci 299: 16–20.
Garland M, Szeto HH, Daniel SS, Tropper P, Myers MM, Stark RI 1996 Zidovudine kinetics in the pregnant baboon. J Acquir Immune Defic Syndr 11: 117–127.
Blum MR, Liao SH, Good SS, de Miranda P 1988 Pharmacokinetics and bioavailability of zidovudine in humans. Am J Med 85: 189–194.
Yoo SD, Rurak DW, Taylor SM, Axelson JE 1993 Transplacental and nonplacental clearances of diphenhydramine in the chronically instrumented pregnant sheep. J Pharm Sci 82: 145–149.
Szeto HH, Umans JG, McFarland J 1982 A comparison of morphine and methadone disposition in the maternal-fetal unit. Am J Obstet Gynecol 143: 700–706.
Riggs KW, Rurak DW, Taylor SM, McErlane BA, McMorland GH, Axelson JE 1990 Fetal and maternal placental and nonplacental clearances of metoclopramide in chronically instrumented pregnant sheep. J Pharm Sci 79: 1056–1061.
Yeleswaram K, Rurak DW, Kwan E, Hall C, Doroudian A, Wright MR, Abbott FS, Axelson JE 1993 Transplacental and nonplacental clearances, metabolism and pharmacodynamics of labetalol in the fetal lamb after direct intravenous administration. J Pharmacol Exp Ther 267: 425–431.
Wang LH, Rudolph AM, Benet LZ 1986 Pharmacokinetic studies of the disposition of acetaminophen in the sheep maternal-placental-fetal unit. J Pharmacol Exp Ther 238: 198–205.
Dutton GJ, Leakey JEA 1981 The perinatal development of drug-metabolizing enzymes: what factors trigger their onset?. Prog Drug Res 25: 189–273.
Valaes TN, Harvey-Wilkes K 1990 Pharmacologic approaches to the prevention and treatment of neonatal hyperbilirubinemia. Clin Perinatol 17: 245–273.
Nathenson G, Cohen MI, Litt IF, McNamara H 1972 The effect of maternal heroin addiction on neonatal jaundice. J Pediatr 81: 899–903.
Watts DH, Brown ZA, Tartaglione T, Burchett SK, Opheim K, Coombs R, Corey L 1991 Pharmacokinetic disposition of zidovudine during pregnancy. J Infect Dis 163: 226–232.
Sperling RS, Roboz J, Dische R, Silides D, Holzman I, Jew E 1992 Zidovudine pharmacokinetics during pregnancy. Am J Perinatol 9: 247–249.
O'Sullivan MJ, Boyer PJJ, Scott GB, Parks W, Weller S, Blum MR, Balsley J, Bryson YJ, Zidovudine Collaborative Working Group 1993 The pharmacokinetics and safety of zidovudine in the third trimester of pregnancy for women infected with human immunodeficiency virus and their infants: Phase I Acquired Immunodeficiency Syndrome Clinical Trials Group study (protocol 082). Am J Obstet Gynecol 168: 1510–1516.
Chavanet P, Diquet B, Waldner A, Portier H 1989 Perinatal pharmacokinetics of zidovudine. N Engl J Med 321: 1548–1549.
Acknowledgements
The authors thank Burroughs Wellcome for supplying the zidovudine and Dr. T. Cooper, New York State Psychiatric Institute, for performing the zidovudine analyses.
Author information
Authors and Affiliations
Additional information
Supported by National Institutes of Health Grant AI32314 and the Aaron Diamond Foundation. M.G. is the recipient of an Aaron Diamond Postdoctoral Research Fellowship Award.
Rights and permissions
About this article
Cite this article
Garland, M., Szeto, H., Daniel, S. et al. Placental Transfer and Fetal Metabolism of Zidovudine in the Baboon. Pediatr Res 44, 47–53 (1998). https://doi.org/10.1203/00006450-199807000-00008
Received:
Accepted:
Issue date:
DOI: https://doi.org/10.1203/00006450-199807000-00008
